Additionally, we identified unexpected recurrent mutations in SETBP1 (7.7%), FAT1, and TACC2 (6.4% each), and a considerable low frequency of NPM1 (2.4%), the latter usually occurring in roughly 30% of adult AML cases [2]. This evidence concerns the gene TACC2 and acute myeloid leukemia.